Menu
Washingtoner
  • Home
  • Financial
  • Technology
  • Non-profit
  • Boeing
  • Business
  • Services
  • Daryl Guberman
  • Education
Washingtoner

The new MyoVision SERIES-5 DynaROM changes lives one patient at a time.
Washingtoner/10113345

Trending...
  • Spokane: Indian Canyon Golf Course Opens Thursday, March 12, 2026
  • The Media Should Protect the Public When It Comes to Boeing — But Does It?
  • The GUBERMAN Anomaly: Boeing's Alliance with ANSI–ANAB Exposed in Federal Contract 19AQMM18R0131
SEATTLE, May 14, 2021 /PRNewswire/ -- Case No 16-2-29568-1 SEA involved a handyman living a very peaceful, simple life. He was not wealthy by any means, but he loved his work and life was good. That was until one day while waiting at a stoplight, a vehicle struck him from behind at approximately 45 MPH, changing his life forever. His new normal included not being able to work, $70,000 in medical bills, struggling daily with chronic pain, the mental anguish of no one believing him, and learning the hard way just how poor his insurance coverage was. To further exacerbate his predicament, his injuries and pain were not corroborated with X-Rays, MRI's, CT Scans or Range of Motion.

His doctor, frustrated with the lack of findings, did some research and discovered MyoVision's DynaROM Motion EMG (a diagnostic tool that can prove the presence or absence of soft tissue injury) was being used by South Korean Orthopedic Surgeons to document soft tissue injury. The DynaROM was also published in the AMA's guidebook "A Practical Guide to Range of Motion Assessment," with the author referring to it as the "new gold standard" as it was more sensitive to soft tissue injury than ROM alone. The DynaROM simultaneously measures range of motion and the muscle response during motion giving it the ability to document muscle guarding (the body's natural response to pain). So the handyman's doctor ordered a DynaROM test and what happened next made history. The jury awarded $958K; one of the largest soft tissue injury awards in history.

More on Washingtoner
  • The "Unsexy" Business Quietly Creating 130+ New Entrepreneurs Across America — From Alaska to Puerto Rico
  • Veteran Launches GTG Energy: Nicotine-Free Pouch as Americans Rethink Addiction, Focus, and What Fuels Performance
  • City of Tacoma Elevates 28-Year South African Sister City Relationship to District-Wide Partnership
  • RecallSentry™ App Launch — Your Home Safety Hub — Free on iOS & Android
  • Award-Winning Director Crystal J. Huang's Under-$50K Film "The Ritual House" Wins Best Horror Feature at Golden State Film Festival

The handyman described the DynaROM as, "The missing puzzle piece that validated my pain.  The jury understood the simple graphics that proved the insurance defense wrong. The DynaROM was essential to obtaining the award, and I am forever grateful that it has allowed me to continue care and the work I love, but at a pace which does not leave me in constant pain."

About the MyoVision SERIES-5 DynaROM

Developed under a prestigious NIH Grant, the new SERIES-5 is the result of thousands of hours of R&D and clinical application in the healthcare arena. MyoVision has been manufacturing medical equipment in the US for the past 30 years. For more information, visit myovision.com or email [email protected]

SOURCE MyoVision

Related Links

https://www.myovision.com/
Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Energywise Solutions and Pickleball Pros Partner to Bring More Energy and Visibility to Pickleball Clubs
  • Buildout Launches CRM, Completing the Industry's First AI-Powered End-to-End Deal Engine for CRE
  • The Franchise King® Releases Free Guide for Nervous Buyers
  • The Unsweetened Tooth Declares the End of Sugar‑Spiked Cookies
  • Kanguro Insurance Taps Paylode to Launch Best-in-Class Pet and Renters Insurance Rewards Experience
  • CCHR: CIA Mind-Control Files Raise Urgent Questions as Millions Take Psychotropic Drugs
  • NRx Pharmaceuticals Launches Breakthrough One-Day Treatment Clinic in Florida as FDA Pathway and Clinical Data Strengthen Growth Outlook; $NRXP
  • Revenue Optics Launches Talent Infrastructure Platform for SaaS Revenue Hiring and Appoints Sabz Kaur to Lead Growth
  • Building a Multi-Domain Autonomous Systems Platform at the Intersection of AI, Defense and Infrastructure: VisionWave Holdings (N A S D A Q: VWAV)
  • Bent Danholm Named "Top Luxury Real Estate Leader" in Modern Luxury Miami
  • Window Sticker Lookup By VIN Launches Free Direct OEM Monroney Label Lookups
  • Author Ken Mora to Celebrate New Caravaggio Book Debut with Special Event at Palazzo Venezia Naples
  • Matthew Sisneros Releases Raw and Unfiltered Memoir: The Devil Lost Another One — A Powerful Story of Crime, Consequence, and Redemption
  • From Life to Light: Jess L. Martinez Shares a Soulful Poetry Collection That Explores What It Means to Be Human
  • Lawsuit Filed Against Boeing Over Defective Seat Switch on Boeing 787
  • Quadcode Acquires Significant Stake in Game 7, LLC - The Parent Company for FPFX Tech and PropAccount.com
  • Danholm Collection Announces Sale of 16689 Broadwater Ave in Winter Garden, Highlighting Strong Performance in Twinwaters Community
  • Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA
  • 46th International Symposium On Forecasting – Dates, Venue And Speakers Announced
  • Phoenix Rebellion Therapy Celebrates 10 Years Helping Utahns Overcome Trauma as Utah Faces Nation's 2nd-Highest Rate of Mental Health Challenges
_catLbl0 _catLbl1

Popular on Washingtoner

  • OneVizion Announces Next Phase of Growth as Brad Kitchens Joins Board of Directors - 165
  • Still Using Ice? FrostSkin Reinvents Hydration - 112
  • Male In Custody After North Spokane Drive By Shooting
  • Spokane: 2026 Safe Streets For All (Traffic Calming) Updates
  • Cold. Clean. Anywhere. Meet FrostSkin
  • Tacoma: Applicants Sought for the Public Utility Board
  • Ice Melts. Infrastructure Fails. What Happens to Clean Water?
  • Spokane: Water Wise Wednesday Workshops Begin March 4
  • Primeindexer Google indexing platform launched by SEO Danmark APS
  • Tacoma City Council Announces City Manager Finalists

Similar on Washingtoner

  • Scotch Whisky Market Dislocation Creates Compelling Entry Opportunity for Long-Term Investors
  • $6 Million Funding Secured as Retail Expansion, Operational Streamlining, and Asset-Light Strategy Position the Company for Accelerated Growth $SOWG
  • The "Unsexy" Business Quietly Creating 130+ New Entrepreneurs Across America — From Alaska to Puerto Rico
  • Veteran Launches GTG Energy: Nicotine-Free Pouch as Americans Rethink Addiction, Focus, and What Fuels Performance
  • K2 Integrity Enhances Technology Capabilities Through Acquisition of Leviathan Security Group
  • Energywise Solutions and Pickleball Pros Partner to Bring More Energy and Visibility to Pickleball Clubs
  • Buildout Launches CRM, Completing the Industry's First AI-Powered End-to-End Deal Engine for CRE
  • The Franchise King® Releases Free Guide for Nervous Buyers
  • NRx Pharmaceuticals Launches Breakthrough One-Day Treatment Clinic in Florida as FDA Pathway and Clinical Data Strengthen Growth Outlook; $NRXP
  • Revenue Optics Launches Talent Infrastructure Platform for SaaS Revenue Hiring and Appoints Sabz Kaur to Lead Growth
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute